ELIZABETH RANKIN: Open Payments
NPI 1407574247 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 20 payments from 11 companies in 2025. Trend: 2023 $321 · 2024 $292 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $178 |
| QOL Medical, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: MAVYRET, RINVOQ, Sucraid, ENTYVIO, LINZESS, Axonics, REBYOTA, ZENPEP.
Industry payments across SC — which companies pay providers there.
